Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease
Identifieur interne : 001741 ( PascalFrancis/Checkpoint ); précédent : 001740; suivant : 001742Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease
Auteurs : P. Limousin [France] ; P. Pollak [France] ; J. P. Pfeffen ; C. L. Tournier-Gervason [France] ; R. Dubuis ; J. E. Perret [France]Source :
- Clinical neuropharmacology [ 0362-5664 ] ; 1995.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:95-0422394Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease</title>
<author><name sortKey="Limousin, P" sort="Limousin, P" uniqKey="Limousin P" first="P." last="Limousin">P. Limousin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P." last="Pollak">P. Pollak</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeffen, J P" sort="Pfeffen, J P" uniqKey="Pfeffen J" first="J. P." last="Pfeffen">J. P. Pfeffen</name>
</author>
<author><name sortKey="Tournier Gervason, C L" sort="Tournier Gervason, C L" uniqKey="Tournier Gervason C" first="C. L." last="Tournier-Gervason">C. L. Tournier-Gervason</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubuis, R" sort="Dubuis, R" uniqKey="Dubuis R" first="R." last="Dubuis">R. Dubuis</name>
</author>
<author><name sortKey="Perret, J E" sort="Perret, J E" uniqKey="Perret J" first="J. E." last="Perret">J. E. Perret</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">95-0422394</idno>
<date when="1995">1995</date>
<idno type="stanalyst">PASCAL 95-0422394 INIST</idno>
<idno type="RBID">Pascal:95-0422394</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001872</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001775</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001741</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">001741</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease</title>
<author><name sortKey="Limousin, P" sort="Limousin, P" uniqKey="Limousin P" first="P." last="Limousin">P. Limousin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P." last="Pollak">P. Pollak</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Pfeffen, J P" sort="Pfeffen, J P" uniqKey="Pfeffen J" first="J. P." last="Pfeffen">J. P. Pfeffen</name>
</author>
<author><name sortKey="Tournier Gervason, C L" sort="Tournier Gervason, C L" uniqKey="Tournier Gervason C" first="C. L." last="Tournier-Gervason">C. L. Tournier-Gervason</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Dubuis, R" sort="Dubuis, R" uniqKey="Dubuis R" first="R." last="Dubuis">R. Dubuis</name>
</author>
<author><name sortKey="Perret, J E" sort="Perret, J E" uniqKey="Perret J" first="J. E." last="Perret">J. E. Perret</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region>
<region type="old region" nuts="2">Rhône-Alpes</region>
<settlement type="city">Grenoble</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
<imprint><date when="1995">1995</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Clinical neuropharmacology</title>
<title level="j" type="abbreviated">Clin. neuropharmacol.</title>
<idno type="ISSN">0362-5664</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson agent</term>
<term>Chemotherapy</term>
<term>Dopa</term>
<term>Double blind study</term>
<term>Drug combination</term>
<term>Enzyme inhibitor</term>
<term>Human</term>
<term>Oral administration</term>
<term>Parkinson disease</term>
<term>Placebo</term>
<term>Treatment efficiency</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Antiparkinsonien</term>
<term>Inhibiteur enzyme</term>
<term>Association médicamenteuse</term>
<term>Chimiothérapie</term>
<term>Efficacité traitement</term>
<term>Homme</term>
<term>Voie orale</term>
<term>Parkinson maladie</term>
<term>Etude double insu</term>
<term>Placebo</term>
<term>Tolcapone</term>
<term>Dopa</term>
<term>Bensérazide</term>
<term>Catechol methyltransferase</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0362-5664</s0>
</fA01>
<fA02 i1="01"><s0>CLNEDB</s0>
</fA02>
<fA03 i2="1"><s0>Clin. neuropharmacol.</s0>
</fA03>
<fA05><s2>18</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LIMOUSIN (P.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>POLLAK (P.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>PFEFFEN (J. P.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>TOURNIER-GERVASON (C. L.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>DUBUIS (R.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>PERRET (J. E.)</s1>
</fA11>
<fA14 i1="01"><s1>Joseph Fourier univ. Grenoble, dep. clin. biological neurosci.</s1>
<s2>38043 Grenoble</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>6 aut.</sZ>
</fA14>
<fA20><s1>258-265</s1>
</fA20>
<fA21><s1>1995</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>16720</s2>
<s5>354000050914840060</s5>
</fA43>
<fA44><s0>0000</s0>
</fA44>
<fA45><s0>27 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>95-0422394</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Clinical neuropharmacology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC02 i1="01" i2="X"><s0>002B02B06</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Antiparkinsonien</s0>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Antiparkinson agent</s0>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Antiparkinsoniano</s0>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Inhibiteur enzyme</s0>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Enzyme inhibitor</s0>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Inhibidor enzima</s0>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Association médicamenteuse</s0>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Drug combination</s0>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Asociación medicamentosa</s0>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Efficacité traitement</s0>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Treatment efficiency</s0>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Eficacia tratamiento</s0>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Voie orale</s0>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Oral administration</s0>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Vía oral</s0>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Etude double insu</s0>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Double blind study</s0>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Estudio doble ciego</s0>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Placebo</s0>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Placebo</s0>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Placebo</s0>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Tolcapone</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Dopa</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Bensérazide</s0>
<s2>NK</s2>
<s2>FR</s2>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Catechol methyltransferase</s0>
<s2>FE</s2>
<s4>INC</s4>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Enzyme</s0>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Enzyme</s0>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Enzima</s0>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cerebral disorder</s0>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Encéfalo patología</s0>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Degenerative disease</s0>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
</fC07>
<fN21><s1>240</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations><list><country><li>France</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
</region>
<settlement><li>Grenoble</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Dubuis, R" sort="Dubuis, R" uniqKey="Dubuis R" first="R." last="Dubuis">R. Dubuis</name>
<name sortKey="Pfeffen, J P" sort="Pfeffen, J P" uniqKey="Pfeffen J" first="J. P." last="Pfeffen">J. P. Pfeffen</name>
</noCountry>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Limousin, P" sort="Limousin, P" uniqKey="Limousin P" first="P." last="Limousin">P. Limousin</name>
</region>
<name sortKey="Perret, J E" sort="Perret, J E" uniqKey="Perret J" first="J. E." last="Perret">J. E. Perret</name>
<name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P." last="Pollak">P. Pollak</name>
<name sortKey="Tournier Gervason, C L" sort="Tournier Gervason, C L" uniqKey="Tournier Gervason C" first="C. L." last="Tournier-Gervason">C. L. Tournier-Gervason</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001741 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 001741 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= PascalFrancis |étape= Checkpoint |type= RBID |clé= Pascal:95-0422394 |texte= Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |